drugset / Trial / NCT00665418

Sevoflurane and Laryngeal Reflex Responses in Pediatric Patients

NCT00665418

Phase 4 Terminated 40 enrolled University Hospital, Basel, Switzerland
NaSingle-groupOpen-labelPrevention

Summary

To describe laryngeal and respiratory reflex responses after controlled laryngeal stimulation in pediatric patients anesthetized with sevoflurane and to compare the evoked responses at two levels of anesthesia. To determine whether laryngeal and respiratory reflex responses after controlled laryngeal stimulation are completely suppressed in subjects when anesthetized with a MACEI95 (EI = endotracheal intubation) sevoflurane Hypothesis: The incidence of apnea with laryngospasm evoked by laryngeal stimulation will be reduced by 20% (from 25% to 5%) when the end-tidal concentration of sevoflurane is increased from 2.5% (MAC50) to 4.7% (MACEI95)

Timeline

Start
2008-02
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Sevoflurane Other / unclassified 2.5 % Inhaled
Subject Sevoflurane Other / unclassified 4.7 % Inhaled

Indications